This study is not yet accepting patients
Targeted Investigation of Microbiome Elimination
Summary
- Eligibility
- for people ages 18-80 (full criteria)
- Location
- at La Jolla, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Richard Gallo, M.D., Ph.D.Tissa Hata, M.D.
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientists at UCSD
- Richard Gallo, M.D., Ph.D.
Our laboratory discovered that antimicrobial peptides (AMPs) are produced by mammalian skin and we continue in the discovery of mechanisms and functions of the human skin immune system and microbiome. - Tissa Hata, M.D.
Clinical Professor, Dermatology, Vc-health Sciences-schools. Authored (or co-authored) 57 research publications
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Links
- Atopic Dermatitis Research Network (ADRN) National Institute of Allergy and Infectious Diseases (NIAID) Division of Allergy, Immunology, and Transplantation (DAIT)
- ID
- NCT05177328
- Phase
- Phase 1 Atopic Dermatitis (Eczema) Research Study
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated